Skip to main content
Log in

Gestationsdiabetes

Gestational diabetes mellitus

  • Leitthema
  • Published:
Gynäkologische Endokrinologie Aims and scope

Zusammenfassung

Der Diagnostik und Therapie des Gestationsdiabetes wurde durch neue Studienergebnisse und die aktuelle Leitlinie ein neuer Rahmen gesteckt. Die Diagnostik stützt sich auf ein 2-stufiges Screening aller Schwangeren mit exakten Anweisungen zur venösen Blutentnahme und einheitlichen Grenzwerten. Für die Therapie und die Betreuung während der Schwangerschaft gibt es nun ebenfalls eine verbindliche Empfehlung, um eine angemessene und risikoadaptierte Betreuung anhand von Blutzuckerwerten, maternalen Vorerkrankungen und fetaler Entwicklung zu gewährleisten. Der vorliegende Artikel soll einen Überblick über diese Entwicklungen und einen Ausblick auf die praktische Umsetzung geben.

Abstract

The diagnostics and therapy of gestational diabetes mellitus (GDM) have been changed by new scientific results and new guidelines. The GDM diagnostics are now based on a two step screening program for all pregnant women with uniform measurement limits and exact standards for venous blood sampling. There are also obligatory recommendations about care and therapy during pregnancy to ensure an adequate management according to blood sugar measurements, maternal risk profile and fetal development. This article presents a summary of recent developments and an outlook on practical issues of GDM management.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1
Abb. 2

Literatur

  1. Balsells M, García-Patterson A, Gich I, Corcoy R (2009) Maternal and fetal outcome in women with type 2 versus type 1 diabetes mellitus: a systematic review and metaanalysis. J Clin Endocrinol Metab 94:4284–4291

    Google Scholar 

  2. Bellamy L, Casas JP, Hingorani AD, Williams D (2009) Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet 373:1773–1779

    Article  PubMed  CAS  Google Scholar 

  3. Bonomo M, Cetin I, Pisoni MP et al (2004) Flexible treatment of gestational diabetes modulated on ultrasound evaluation of intrauterine growth: a controlled randomized clinical trial. Diabetes Metab 30:237–244

    Article  PubMed  CAS  Google Scholar 

  4. Buchanan TA, Kjos SL, Montoro MN et al (1994) Use of fetal ultrasound to select metabolic therapy for pregnancies complicated by mild gestational diabetes. Diabetes Care 17:275–283

    Article  PubMed  CAS  Google Scholar 

  5. Crowther CA, Hiller JE, Moss JR et al (2005) Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med 352:2477–2486

    Google Scholar 

  6. Hanley B, Dijane J, Fewtrell M et al (2010) Metabolic imprinting, programming and epigenetics – a review of present priorities and future opportunities. Br J Nutr 104(Suppl 1):1–25

    Article  Google Scholar 

  7. Hillier TA, Pedula KL, Schmidt MM et al (2007) Childhood obesity and metabolic imprinting: the ongoing effects of maternal hyperglycemia. Diabetes Care 30:2287–2292

    Article  PubMed  Google Scholar 

  8. Hüttner U, Kainer F, Weiss PA, Haas J (1997) Fetal ultrasound biometry and amniotic fluid insulin concentration in pregnant diabetic patients. Gynakol Geburtshilfliche Rundsch 37:21–24

    Article  PubMed  Google Scholar 

  9. Kautzky-Willer A, Prager R, Waldhausl W et al (1997) Pronounced insulin resistance and inadequate beta-cell secretion characterize lean gestational diabetes during and after pregnancy. Diabetes Care 20:1717–1723

    Article  PubMed  CAS  Google Scholar 

  10. Kerner W, Brückel J (2010) Definition, Klassifikation und Diagnostik des Diabetes mellitus. Diabetologie 5(Suppl 2):109–112

    Article  Google Scholar 

  11. Landon MB, Spong CY, Thom E et al (2009) A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med 361:1339–1348

    Google Scholar 

  12. Metzger BE, Lowe LP, Dyer AR et al (2008) Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 358:1991–2002

    Google Scholar 

  13. Schaefer-Graf UM, Kjos SL, Fauzan OH et al (2004) A randomized trial evaluating a predominantly fetal growth-based strategy to guide management of gestational diabetes in Caucasian women. Diabetes Care 27:297–302

    Article  PubMed  Google Scholar 

  14. Schäfer-Graf UM et al (2012) Gestationsdiabetes: Blutzuckerscreening jetzt Bestandteil der Mutterschaftsrichtlinie. Frauenarzt 53:220

    Google Scholar 

  15. Virally M, Laloi-Michelin M (2010) Methods for the screening and diagnosis of gestational diabetes mellitus between 24 and 28 weeks of pregnancy. Diabetes Metab 36(6 Pt 2):549–565

    Article  PubMed  CAS  Google Scholar 

  16. Weiss P, Hofmann H, Kainer F, Haas J (1988) Fetal outcome in gestational diabetes with elevated amniotic fluid insulin levels. Dietary versus insulin treatment. Diabetes Res Clin Pract 5:1–7

    Article  PubMed  CAS  Google Scholar 

  17. Xiang AH, Kjos SL, Takayanagi M et al (2010) Detailed physiological characterization of the development of type 2 diabetes in Hispanic women with prior gestational diabetes mellitus. Diabetes 59:2625–2630

    Article  PubMed  CAS  Google Scholar 

Download references

Interessenkonflikt

Der korrespondierende Autor gibt für sich und seinen Koautor an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to S. Hutter.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hutter, S., Kainer, F. Gestationsdiabetes. Gynäkologische Endokrinologie 10, 184–189 (2012). https://doi.org/10.1007/s10304-012-0488-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10304-012-0488-4

Schlüsselwörter

Keywords

Navigation